| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |